(VIANEWS) – The NASDAQ ended the session with Amgen rising 4.29% to $255.26 on Monday, after five sequential sessions in a row of gains. NASDAQ jumped 3.33% to $12,131.13, after three sequential sessions in a row of gains, on what was a very bullish trend trading session today.
Today’s last reported volume for Amgen is 2678950, 13.82% below its average volume of 3108580.
Amgen’s last close was $255.26, 1.23% under its 52-week high of $258.45.
The company’s growth estimates for the present quarter is 0.5% and a drop 1.7% for the next.
Year-on-year quarterly revenue growth grew by 5.7%, now sitting on 26.32B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Amgen’s stock is considered to be oversold (<=20).
Amgen’s Stock Yearly Top and Bottom Value
Amgen’s stock is valued at $255.26 at 18:41 EST, below its 52-week high of $258.45 and way above its 52-week low of $198.64.
Amgen’s Moving Average
Amgen’s value is higher than its 50-day moving average of $244.70 and way higher than its 200-day moving average of $225.48.
More news about Amgen (AMGN).